Berry Genomics Co.,Ltd Sustainability Profile
Berry Genomics Co., Ltd., headquartered in China, is a leading player in the genomics industry, specialising in advanced genetic testing and precision medicine. Founded in 2010, the company has rapidly established itself as a pioneer in the field, with significant operational presence across Asia and beyond. The firm offers a range of innovative products and services, including non-invasive prenatal testing (NIPT) and comprehensive genomic profiling, which are distinguished by their accuracy and reliability. Berry Genomics is committed to enhancing healthcare through cutting-edge technology and has achieved notable milestones, such as extensive partnerships with healthcare institutions and a strong market position in genetic diagnostics. With a focus on research and development, Berry Genomics continues to drive advancements in genomics, making significant contributions to personalised medicine and improving patient outcomes.
DitchCarbon Score
How does Berry Genomics Co.,Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Berry Genomics Co.,Ltd's score of 22 is lower than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Berry Genomics Co.,Ltd's reported carbon emissions
Berry Genomics Co., Ltd, headquartered in China, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges from the company. This lack of data suggests that Berry Genomics may not have established formal commitments to reduce carbon emissions or may not publicly disclose such information. In the context of the industry, many companies are increasingly adopting science-based targets and sustainability initiatives to address climate change. However, without specific emissions data or commitments, it is challenging to assess Berry Genomics' position relative to its peers in the genomics sector.
How Carbon Intensive is Berry Genomics Co.,Ltd's Industry?
How Carbon Intensive is Berry Genomics Co.,Ltd's Location?
Berry Genomics Co.,Ltd's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Berry Genomics Co.,Ltd has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.